Corey Levenson
Keine laufenden Positionen mehr
Profil
Corey Levenson worked as a Senior Director-Licensing at ILEX Oncology, Inc. from 1996 to 2004.
Prior to that, he was the Director-Nucleic Acid Chemistry at Cetus Corp.
from 1981 to 1991.
He also worked as the Director & Chief Technology Officer at OncoVista Innovative Therapies, Inc. in 2007-2008.
He served as the Chief Scientific Officer at ViroXis Corp.
and as the Chief Technology Officer at OncoVista, Inc. Additionally, he worked as a Senior Research Investigator at Roche Molecular Systems, Inc. from 1991 to 1996.
Levenson received his undergraduate degree from Hampshire College in 1976 and his doctorate from The University of California, San Francisco in 1981.
Ehemalige bekannte Positionen von Corey Levenson
| Unternehmen | Position | Ende |
|---|---|---|
OncoVista, Inc.
 OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | Technik-/Wissenschafts-/F&E-Leiter | 14.01.2008 |
| ONCOVISTA INNOVATIVE THERAPIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.01.2008 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Corporate Officer/Principal | 01.12.2004 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Corporate Officer/Principal | 01.01.1996 |
| Cetus Corp. | Corporate Officer/Principal | 01.01.1991 |
Ausbildung von Corey Levenson
| Hampshire College | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOVISTA INNOVATIVE THERAPIES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
ViroXis Corp.
 ViroXis Corp. BiotechnologyHealth Technology ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX. | Health Technology |
| Cetus Corp. | Health Technology |
OncoVista, Inc.
OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | Electronic Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
